References
- Logroscino G, Traynor BJ, Hardiman O et al. Incidence of amyotrophic lateral sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry81(4), 385–390 (2010).
- de Carvalho M, Swash M. Amyotrophic lateral sclerosis: an update. Curr. Opin. Neurol.24(5), 497–503 (2011).
- Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev.24(1), CD001447 (2007).
- Foster S. The role of patients and patient advocacy groups in educating patients on the importance of legitimate scientific research. Am. J. Bioeth.10(5), 49 (2010).
- Rabinowitz JD, White E. Autophagy and metabolism. Science330(6009), 1344–1348 (2010).
- Komatsu M, Waguri S, Chiba T et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature441(7095), 880–884 (2006).
- Hara T, Nakamura K, Matsiu M et al. Suppression of basal autophagy in neural cells causes neurodegeneative disease in mice. Nature441(7095), 885–889 (2006).
- Filimonenko M, Stuffers S, Raiborg C et al. Functional multivesicular bodies are required for autophagic clearance of protein associated with neurodegenerative disease. J. Cell Biol.179(3), 485–490 (2007).
- Price LH, Heninger GR. Lithium in the treatment of mood disorders. N. Engl. J. Med.331(9), 591–598 (1994).
- Fornai F, Longone P, Cafaro L et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA105(6), 2052–2057 (2008).
- Shin JH, Cho I, Lim HR et al. Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis. Mol. Pharmacol.71(4), 965–975 (2000).
- Meningier V, Shefner J, Cudkowicz M. Lithium therapy in ALS. Amyotroph. Lateral Scler.9(2), 122 (2008).
- Pizzasegola C, Caron I, Daleno C et al. Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. Amyotroph. Lateral Scler.10(4), 221–228 (2009).
- Gill A, Kidd J, Vieira F, Thompson K, Perrin S. No benefit from chronic lithium dosing in a sibling-matched, gender-balanced, investigator-blinded, trial using a standard mouse model of familial ALS. PLoS One4(8), e6489 (2009).
- Wicks P, Massagli M, Frost J, Macedo H, Felzer K, Heywood J. A patient-led trial of lithium in ALS using the internet. Amyotroph. Lateral Scler.9(Suppl. 1), 59 (2008).
- Aggarwal SP, Zinman I, Simpson E et al. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. Lancet Neurol.9(5), 481–488 (2010).
- Chiò A, Borghero G, Calvo A, et al. Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology75(7), 619–625 (2010).
- Miller RG, Forshew D, Katz J et al. Phase II controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis. Neurology77(10), 973–979 (2011).